Vivani Medical, Inc. (VANI) Stock Price & Growth Analysis - Tweevest

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Vivani Medical, Inc.

VANI

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

62M

Medical - Devices

Next Earning date - 12 Nov 2024

62M

Medical - Devices

Next Earning date - 12 Nov 2024

1.13USD

0.02 ( 1.80%)

Relative Strenght

55

Volume Buzz

-59%

Earning Acce

No

Dist 52w H.

86%

Quote Panel

Updated October 12, 2024

1W -1.74 % 1M -12.40 % 3M -15.04 % 1Y 13.00 %

Key Metrics

Market Cap
62.44M
Shares Outstanding
55.26M
Share in Float
30.19M
Dividende
0

Earning Date
12 Nov 2024
Price Target
1.13
Average Volume
80354
Beta
3.596

Range
0.84-7.8
Industry
Medical - Devices
Website
https://www.vivani.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

120.54x

P/S Ratio

2.61x

P/B Ratio

0.8

Debt/Equity

-4672.4%

Net Margin

$-0.5

EPS

How VANI compares to sector?

P/E Ratio

Relative Strength

VANI

Sector

loading...

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

0

$0.50

-414%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

ThinkEquity

initialise

Previous: Not converted

2022-12-05

Now: Buy

Morgan Stanley

initialise

Previous: Not converted

2022-12-05

Now: Underweight

Craig-Hallum

initialise

Previous: Not converted

2022-12-05

Now: Buy

EF Hutton

initialise

Previous: Not converted

2022-12-05

Now: Buy

Earnings Growth

YoY

Current

Estimates

Q3.22

+138%

0.04
vs -0.11

Q4.22

N/A

-0.18
vs -0.09

Q1.23

N/A

-0.12
vs -0.12

Q2.23

N/A

-0.13
vs -0.08

Q3.23

N/A

-0.13
vs 0.04

Q4.23

N/A

-0.12
vs -0.18

Q1.24

N/A

-0.12
vs -0.12

Q2.24

N/A

-0.10
vs -0.13

Q3.24

N/A

-0.11
vs -0.13

Q4.24

N/A

-0.12
vs -0.12

Sales Growth

YoY

Current

Estimates

Q1.22

NA

NA vs NA

Q2.22

NA

NA vs NA

Q3.22

NA

NA vs NA

Q4.22

-100%

NA vs 260

Q1.23

NA

NA vs NA

Q2.23

NA

NA vs NA

Q3.23

NA

NA vs NA

Q4.23

NA

518K vs NA

Q1.24

NA

NA vs NA

Q2.24

NA

NA vs NA

Return on Equity

QoQ

Q3.22

+16%

0.16
vs 0.86

Q4.22

-15%

-0.15
vs 0.16

Q1.23

-16%

-0.16
vs -0.15

Q2.23

-20%

-0.20
vs -0.16

Q3.23

-26%

-0.26
vs -0.20

Q4.23

-29%

-0.29
vs -0.26

Q1.24

-21%

-0.21
vs -0.29

Q2.24

-22%

-0.22
vs -0.21

Institutionnal Ownership

Earnings Growth

Latest News

VANI

businesswire.com

8 hours ago

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

VANI

businesswire.com

8 hours ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

VANI

businesswire.com

8 hours ago

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

VANI

businesswire.com

8 hours ago

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

VANI

businesswire.com

19 hours ago

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

VANI

investorplace.com

20 hours ago

VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024

New Feature Coming Soon, Stay Tuned!

Shape

Shape